Drilldown: Medicines
Medicines > fda max 
:
4.5 mg/day (Parkinson disease); 0.5 mg/day (restless legs syndrome) or
Indication-specific
& onset:
LDL lowering at 2 weeks, max by 4 weeks
:
4.5 mg/day (Parkinson disease); 0.5 mg/day (restless legs syndrome) or
Indication-specific
& onset:
LDL lowering at 2 weeks, max by 4 weeks Use the filters below to narrow your results.
generic:
(There are no values for this filter)
brand:
(There are no values for this filter)
classes:
(There are no values for this filter)
mechanism:
(There are no values for this filter)
uses:
(There are no values for this filter)
starting dose:
(There are no values for this filter)
preparations:
(There are no values for this filter)
fda max: (Click arrow to add another value)
routes:
(There are no values for this filter)
onset: (Click arrow to add another value)
duration:
(There are no values for this filter)
halflife:
(There are no values for this filter)
bioavailability:
(There are no values for this filter)
pregnancy:
(There are no values for this filter)
legal:
(There are no values for this filter)
There are no results for this report.